For both sides
Single-license vs multi-license portfolio
Federal and state law current as of September 2026 — verify with counsel.
Key takeaways
- As of September 2026, medical marijuana is Schedule III; adult-use remains Schedule I (Federal Register 2026-08176 and pending hearing).
- 280E still hits adult-use SG&A; medical books may take ordinary deductions — apportion dual licenses.
- SBA loans are unavailable for plant-touching targets (SOP 50 10 8).
- Deals close on regulatory approval; control does not move early.
- Single-store commentary multiples of about 3x–6x EBITDA are trade ranges, not appraisals (2025–2026 commentary).
Single-license vs multi-license portfolio is a side-by-side underwriting choice. The wrong column is how buyers overpay and sellers wait a year. This page is written for owners and buyers and for vertical licenses specifically. It is not legal or tax advice.
On Single-license vs multi-license portfolio, the federal overlay is a schedule split, not a national license. Federal Register 2026-08176 moved qualifying medical and FDA-approved marijuana to Schedule III on 28 April 2026. Adult-use marijuana stayed on Schedule I while a DEA hearing record sits with an administrative law judge. That is why IRC §280E still bites adult-use SG&A and why a medical slice can look different after tax.
| Topic | Working rule (verify, September 2026) |
|---|---|
| Audience | owners and buyers |
| License lens | vertical licenses specifically |
| Contrast markets | Illinois / Minnesota / Colorado |
| SBA | Unavailable for plant-touching (SOP 50 10 8) |
| Hemp clock | P.L. 119-37 redefinition 12 November 2026 |
| Commentary multiple (not an appraisal) | 5x–53x normalized earnings |
When to walk away from Single-license vs multi-license portfolio — what should you verify for Single-license vs multi-license portfolio?
If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026, the honest answer is stop. Single-license vs multi-license portfolio is not improved by optimism.
Partner and dispute uses of Single-license vs multi-license portfolio — how should you read this on Single-license vs multi-license portfolio?
Buyouts and shareholder fights still need a method, not a slogan. Label ranges. Do not pretend a liquor-store rule prices Single-license vs multi-license portfolio.
Inventory and biomass on Single-license vs multi-license portfolio — why does this change Single-license vs multi-license portfolio?
What is on the floor at close has to match the state system. Failed tests and unsold canopy are price, not atmosphere. Count it.
Real estate attached to Single-license vs multi-license portfolio — why does this change Single-license vs multi-license portfolio?
The building can be the deal or the trap. No cannabis-use clause means Single-license vs multi-license portfolio cannot operate after assignment. Sale-leasebacks are capital, not magic.
Social-equity paper inside Single-license vs multi-license portfolio — what belongs on Single-license vs multi-license portfolio?
Eligible-transferee rules and holding periods are deal terms. Single-license vs multi-license portfolio that ignores them is a letter, not a close. See social-equity locks.
Distressed paths near Single-license vs multi-license portfolio — what breaks Single-license vs multi-license portfolio?
Receiverships and ABCs exist because chapter 7 and 11 are generally closed to domestic plant-touching debtors. If Single-license vs multi-license portfolio is already in a fiduciary process, price the claims, not last year’s CIM.
The first cut on Single-license vs multi-license portfolio — what breaks Single-license vs multi-license portfolio?
Single-license vs multi-license portfolio is decided before a teaser goes out. both sides who start with a hoped-for multiple skip whether the paper can move. Illinois and Minnesota do not share a packet. vertical licenses specifically is the lens.
Records that prove Single-license vs multi-license portfolio — what should you verify for Single-license vs multi-license portfolio?
Rebuild Single-license vs multi-license portfolio from track-and-trace, tax filings, the lease cannabis-use clause, and a cap table that matches the application. A vanity P&L is a brochure. Buyers spend after-tax cash.
Illinois habits that fail on Single-license vs multi-license portfolio — why does this change Single-license vs multi-license portfolio?
Copying a Illinois habit into Minnesota is how Single-license vs multi-license portfolio dies in review. Colorado is the third check. Published locks (Maryland converted control through 1 July 2028; New Jersey majority changes; California non-assignment) only apply if the premises sit there.
Cash after tax on Single-license vs multi-license portfolio — why does this change Single-license vs multi-license portfolio?
Illustrative only: $374,000 of pre-280E earnings can shrink hard on an adult-use book. Medical Schedule III relief after 28 April 2026 is a slice, not a slogan. Dual shops apportion. IRC §280E is the citation.
Capital that will not appear on Single-license vs multi-license portfolio — what belongs on Single-license vs multi-license portfolio?
SBA SOP 50 10 8 still bars plant-touching 7(a) and 504. SAFE Banking Act of 2026, S.4942 is not a close condition. Single-license vs multi-license portfolio is funded with seller paper, private credit, cash, or a sale-leaseback — or it is not funded.
Local authorization inside Single-license vs multi-license portfolio — how should you read this on Single-license vs multi-license portfolio?
A state yes with a city no is a failed Single-license vs multi-license portfolio. Opt-out, buffers, and CUPs are the site. Read local control before anyone argues price.
People the agency will map on Single-license vs multi-license portfolio — what belongs on Single-license vs multi-license portfolio?
True parties of interest include more than the 51% owner. Silent lenders and handshake managers show up on Single-license vs multi-license portfolio whether the CIM mentions them or not.
Confidentiality rules for Single-license vs multi-license portfolio — what should you verify for Single-license vs multi-license portfolio?
Single-license vs multi-license portfolio is not a Facebook post. Use a blind teaser and an NDA. Employees and landlords in Illinois find out on a planned day.
Cited sources that govern Single-license vs multi-license portfolio: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.
What to bring to the intro call — what breaks Single-license vs multi-license portfolio?
Book twenty minutes with Jason Taken at HedgeStone Business Advisors. For Single-license vs multi-license portfolio, bring the license class, the state, the local authorization status, and whether a buyer or target is already in the room. There is no form on this site and no invented listing book. He is a business broker, not an attorney and not a licensed cannabis operator.
Related pages for Single-license vs multi-license portfolio — what should you verify for Single-license vs multi-license portfolio?
Read plant-touching vs ancillary next if that file is open on Single-license vs multi-license portfolio. buy vs apply is the companion page when Single-license vs multi-license portfolio needs that angle. Keep consideration types in the working set for Single-license vs multi-license portfolio. Read sell next if that file is open on Single-license vs multi-license portfolio. buy is the companion page when Single-license vs multi-license portfolio needs that angle. Keep valuation in the working set for Single-license vs multi-license portfolio. Read retail vs cultivation next if that file is open on Single-license vs multi-license portfolio. MSO vs private is the companion page when Single-license vs multi-license portfolio needs that angle.
Summary on Single-license vs multi-license portfolio — what breaks Single-license vs multi-license portfolio?
Single-license vs multi-license portfolio turns on approval, after-tax cash, and the license class. Federal law current as of September 2026 is a schedule split, not a green light. Verify every rate, cap, and clock with counsel.
Which public sources belong on this file?
Cite FDA cannabis / CBD page, IRS marijuana industry page, eCFR CSA schedules, USDA hemp production. A forum post is not a substitute.
How should you underwrite Single-license vs multi-license portfolio?
Single-license vs multi-license portfolio has to lock as a license-and-tax file. In New York, scarcity can dominate. In Virginia, paper value can be near zero. Cited sources that govern Single-license vs multi-license portfolio: SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E.
| Check | New York | Virginia |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Frequently asked questions
How long can a license transfer take?
Published clocks vary by state and completeness. Treat 60–180+ days after a complete packet as a broker range unless the agency publishes a deadline. New York and Virginia do not share a clock on Single-license vs multi-license portfolio.
Can control move before approval?
Not if you want to keep the license. Stage closing and keep any MSA inside what the statute allows. Single-license vs multi-license portfolio is still an agency event.
Will SBA finance a plant-touching purchase?
No. [SBA SOP 50 10 8](https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs) treats plant-touching marijuana businesses as ineligible for 7(a) and 504, including medical. Single-license vs multi-license portfolio needs another stack.
What does HedgeStone actually do here?
Eligibility pre-screen, confidential match, METRC-aware pricing, and an approval-contingent process. Not a guaranteed price or a guaranteed yes. That is the job on Single-license vs multi-license portfolio.
Is this legal or tax advice?
No. Educational only. Use cannabis-specialized counsel and a 280E-literate CPA. Jason Taken is a business broker, not an attorney and not a licensed operator.
Which records actually prove the story?
Track-and-trace, tax filings, the lease cannabis-use clause, and a cap table that matches the application. A vanity P&L is a brochure when you are underwriting Single-license vs multi-license portfolio.
Sources
- SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
- Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
- Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
- CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620
- IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
- FDA cannabis and CBD page — https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
- IRS marijuana industry — https://www.irs.gov/businesses/small-businesses-self-employed/marijuana-industry
- eCFR 21 CFR chapter II — https://www.ecfr.gov/current/title-21/chapter-II
- Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
- FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)